Review



human triple negative breast cancer cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human triple negative breast cancer cells
    Human Triple Negative Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 26502 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer cells/product/ATCC
    Average 99 stars, based on 26502 article reviews
    human triple negative breast cancer cells - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    ATCC human triple negative breast cancer cells
    Human Triple Negative Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human triple negative breast cancer cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human triple negative breast cancer cells mda mb 231
    Human Triple Negative Breast Cancer Cells Mda Mb 231, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer cells mda mb 231/product/ATCC
    Average 99 stars, based on 1 article reviews
    human triple negative breast cancer cells mda mb 231 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human triple negative breast cancer tnbc cell lines
    Human Triple Negative Breast Cancer Tnbc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer tnbc cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    human triple negative breast cancer tnbc cell lines - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    97
    ATCC hcc1937 human triple negative breast cancer tnbc cells
    Dose-dependent cytotoxic effects of GNT and Apigenin on <t>HCC1937</t> cells evaluated by the MTT assay. ( A ) Dose–response curves showing percentage cell viability plotted against the logarithm of compound concentration (µM). ( B ) Bar graph representation of cell viability at increasing concentrations (10–400 µM) compared to control. Data are presented as mean ± SD ( n = 6)
    Hcc1937 Human Triple Negative Breast Cancer Tnbc Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcc1937 human triple negative breast cancer tnbc cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    hcc1937 human triple negative breast cancer tnbc cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    99
    ATCC human triple negative breast cancer tnbc mda mb 231 cells
    Immunoassay analysis of A IL-1β, B IL-6, C IL-18, D IL-23, E IL-27, F GM-CSF, G TNF-α, H TNF-β, I FLT-1, J IL-10, K VEGF-C, L bFGF, and M SAA1, upon 8 days of 100 nM DEX (M1 DEX) or vehicle (EtOH) treatment during TPH-differentiation to M1 polarized macrophages, or vehicle (EtOH) treatment during differentiation to M2 polarized macrophages ( n = <t>5).</t> <t>N</t> <t>MDA-MB-231</t> cell Matrigel invasion in response to conditioned medium from unpolarized macrophages (M), M1 polarized macrophages (M1), DEX-treated polarized macrophages (M1 DEX), M2 polarized macrophages (M2), and to 10% FBS-containing medium (positive control) ( n = 3). O Effect on MDA-MB-231 proliferation upon 2-day incubation with conditioned medium from M1, M1 DEX, M1 DEX medium with 10 µM GR-inhibitor relacorilant (REL), and medium from M2 macrophages (n = 3). P Matrigel invasion and Q proliferation of MDA-MB-468 cells in response to the same conditioned medium as in N and O ( n = 4). Bars represent mean ± SD in A – M , or ±SEM in ( N , O , P , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons correction, or an unpaired Student’s t -test in ( J ).
    Human Triple Negative Breast Cancer Tnbc Mda Mb 231 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer tnbc mda mb 231 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human triple negative breast cancer tnbc mda mb 231 cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC human triple negative breast cancer tnbc mdamb 231 cells
    Immunoassay analysis of A IL-1β, B IL-6, C IL-18, D IL-23, E IL-27, F GM-CSF, G TNF-α, H TNF-β, I FLT-1, J IL-10, K VEGF-C, L bFGF, and M SAA1, upon 8 days of 100 nM DEX (M1 DEX) or vehicle (EtOH) treatment during TPH-differentiation to M1 polarized macrophages, or vehicle (EtOH) treatment during differentiation to M2 polarized macrophages ( n = <t>5).</t> <t>N</t> <t>MDA-MB-231</t> cell Matrigel invasion in response to conditioned medium from unpolarized macrophages (M), M1 polarized macrophages (M1), DEX-treated polarized macrophages (M1 DEX), M2 polarized macrophages (M2), and to 10% FBS-containing medium (positive control) ( n = 3). O Effect on MDA-MB-231 proliferation upon 2-day incubation with conditioned medium from M1, M1 DEX, M1 DEX medium with 10 µM GR-inhibitor relacorilant (REL), and medium from M2 macrophages (n = 3). P Matrigel invasion and Q proliferation of MDA-MB-468 cells in response to the same conditioned medium as in N and O ( n = 4). Bars represent mean ± SD in A – M , or ±SEM in ( N , O , P , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons correction, or an unpaired Student’s t -test in ( J ).
    Human Triple Negative Breast Cancer Tnbc Mdamb 231 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer tnbc mdamb 231 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human triple negative breast cancer tnbc mdamb 231 cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    97
    ATCC cell lines construction human triple negative breast cancer cell lines
    Immunoassay analysis of A IL-1β, B IL-6, C IL-18, D IL-23, E IL-27, F GM-CSF, G TNF-α, H TNF-β, I FLT-1, J IL-10, K VEGF-C, L bFGF, and M SAA1, upon 8 days of 100 nM DEX (M1 DEX) or vehicle (EtOH) treatment during TPH-differentiation to M1 polarized macrophages, or vehicle (EtOH) treatment during differentiation to M2 polarized macrophages ( n = <t>5).</t> <t>N</t> <t>MDA-MB-231</t> cell Matrigel invasion in response to conditioned medium from unpolarized macrophages (M), M1 polarized macrophages (M1), DEX-treated polarized macrophages (M1 DEX), M2 polarized macrophages (M2), and to 10% FBS-containing medium (positive control) ( n = 3). O Effect on MDA-MB-231 proliferation upon 2-day incubation with conditioned medium from M1, M1 DEX, M1 DEX medium with 10 µM GR-inhibitor relacorilant (REL), and medium from M2 macrophages (n = 3). P Matrigel invasion and Q proliferation of MDA-MB-468 cells in response to the same conditioned medium as in N and O ( n = 4). Bars represent mean ± SD in A – M , or ±SEM in ( N , O , P , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons correction, or an unpaired Student’s t -test in ( J ).
    Cell Lines Construction Human Triple Negative Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines construction human triple negative breast cancer cell lines/product/ATCC
    Average 97 stars, based on 1 article reviews
    cell lines construction human triple negative breast cancer cell lines - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    99
    ATCC human triple negative breast cancer tnbc cell lines hcc1806
    Immunoassay analysis of A IL-1β, B IL-6, C IL-18, D IL-23, E IL-27, F GM-CSF, G TNF-α, H TNF-β, I FLT-1, J IL-10, K VEGF-C, L bFGF, and M SAA1, upon 8 days of 100 nM DEX (M1 DEX) or vehicle (EtOH) treatment during TPH-differentiation to M1 polarized macrophages, or vehicle (EtOH) treatment during differentiation to M2 polarized macrophages ( n = <t>5).</t> <t>N</t> <t>MDA-MB-231</t> cell Matrigel invasion in response to conditioned medium from unpolarized macrophages (M), M1 polarized macrophages (M1), DEX-treated polarized macrophages (M1 DEX), M2 polarized macrophages (M2), and to 10% FBS-containing medium (positive control) ( n = 3). O Effect on MDA-MB-231 proliferation upon 2-day incubation with conditioned medium from M1, M1 DEX, M1 DEX medium with 10 µM GR-inhibitor relacorilant (REL), and medium from M2 macrophages (n = 3). P Matrigel invasion and Q proliferation of MDA-MB-468 cells in response to the same conditioned medium as in N and O ( n = 4). Bars represent mean ± SD in A – M , or ±SEM in ( N , O , P , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons correction, or an unpaired Student’s t -test in ( J ).
    Human Triple Negative Breast Cancer Tnbc Cell Lines Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human triple negative breast cancer tnbc cell lines hcc1806/product/ATCC
    Average 99 stars, based on 1 article reviews
    human triple negative breast cancer tnbc cell lines hcc1806 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Dose-dependent cytotoxic effects of GNT and Apigenin on HCC1937 cells evaluated by the MTT assay. ( A ) Dose–response curves showing percentage cell viability plotted against the logarithm of compound concentration (µM). ( B ) Bar graph representation of cell viability at increasing concentrations (10–400 µM) compared to control. Data are presented as mean ± SD ( n = 6)

    Journal: BMC Pharmacology & Toxicology

    Article Title: Integrated in silico and in vitro evaluation of Genistein and Apigenin as dual inhibitors of PARP1 and ESR1 in breast cancer

    doi: 10.1186/s40360-025-01082-z

    Figure Lengend Snippet: Dose-dependent cytotoxic effects of GNT and Apigenin on HCC1937 cells evaluated by the MTT assay. ( A ) Dose–response curves showing percentage cell viability plotted against the logarithm of compound concentration (µM). ( B ) Bar graph representation of cell viability at increasing concentrations (10–400 µM) compared to control. Data are presented as mean ± SD ( n = 6)

    Article Snippet: HCC1937 human triple-negative breast cancer (TNBC) cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA; Cat. No. CRL-2336).

    Techniques: MTT Assay, Concentration Assay, Control

    Immunoassay analysis of A IL-1β, B IL-6, C IL-18, D IL-23, E IL-27, F GM-CSF, G TNF-α, H TNF-β, I FLT-1, J IL-10, K VEGF-C, L bFGF, and M SAA1, upon 8 days of 100 nM DEX (M1 DEX) or vehicle (EtOH) treatment during TPH-differentiation to M1 polarized macrophages, or vehicle (EtOH) treatment during differentiation to M2 polarized macrophages ( n = 5). N MDA-MB-231 cell Matrigel invasion in response to conditioned medium from unpolarized macrophages (M), M1 polarized macrophages (M1), DEX-treated polarized macrophages (M1 DEX), M2 polarized macrophages (M2), and to 10% FBS-containing medium (positive control) ( n = 3). O Effect on MDA-MB-231 proliferation upon 2-day incubation with conditioned medium from M1, M1 DEX, M1 DEX medium with 10 µM GR-inhibitor relacorilant (REL), and medium from M2 macrophages (n = 3). P Matrigel invasion and Q proliferation of MDA-MB-468 cells in response to the same conditioned medium as in N and O ( n = 4). Bars represent mean ± SD in A – M , or ±SEM in ( N , O , P , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons correction, or an unpaired Student’s t -test in ( J ).

    Journal: Cell Death & Disease

    Article Title: Dexamethasone drives macrophage repolarization linked to increased triple-negative breast cancer aggressiveness

    doi: 10.1038/s41419-025-08363-9

    Figure Lengend Snippet: Immunoassay analysis of A IL-1β, B IL-6, C IL-18, D IL-23, E IL-27, F GM-CSF, G TNF-α, H TNF-β, I FLT-1, J IL-10, K VEGF-C, L bFGF, and M SAA1, upon 8 days of 100 nM DEX (M1 DEX) or vehicle (EtOH) treatment during TPH-differentiation to M1 polarized macrophages, or vehicle (EtOH) treatment during differentiation to M2 polarized macrophages ( n = 5). N MDA-MB-231 cell Matrigel invasion in response to conditioned medium from unpolarized macrophages (M), M1 polarized macrophages (M1), DEX-treated polarized macrophages (M1 DEX), M2 polarized macrophages (M2), and to 10% FBS-containing medium (positive control) ( n = 3). O Effect on MDA-MB-231 proliferation upon 2-day incubation with conditioned medium from M1, M1 DEX, M1 DEX medium with 10 µM GR-inhibitor relacorilant (REL), and medium from M2 macrophages (n = 3). P Matrigel invasion and Q proliferation of MDA-MB-468 cells in response to the same conditioned medium as in N and O ( n = 4). Bars represent mean ± SD in A – M , or ±SEM in ( N , O , P , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons correction, or an unpaired Student’s t -test in ( J ).

    Article Snippet: The human monocytic cell line THP-1, human triple-negative breast cancer (TNBC) MDA-MB-231 cells, human TNBC MDA-MB-468 cells, and the mouse TNBC luciferase-expressing 4T1-Luc2 cells were obtained from ATCC (#TIB-202, #HTB-26, #HTB-132, #CRL-2539-LUC2; respectively) and propagated in ATCC-modified RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) (both from Gibco; #A1049101, #10500064; respectively).

    Techniques: Positive Control, Incubation